This company seems to have been delisted
Reason: Rebranded as Talphera
Last recorded trade on: March 13, 2024
Source: https://www.fiercepharma.com/marketing/acelrx-becomes-talphera-adopting-new-name-reflect-pain-pivot
Reason: Rebranded as Talphera
Last recorded trade on: March 13, 2024
Source: https://www.fiercepharma.com/marketing/acelrx-becomes-talphera-adopting-new-name-reflect-pain-pivot
AcelRx Pharmaceuticals
ACRX
0,74 €
Share price
7.50%
Change (1 day)
31.59%
Change (1 year)
Categories
AcelRx Pharmaceuticals (ACRX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : €5.42 Million
According to AcelRx Pharmaceuticals 's latest financial reports the company's total liabilities are €5.42 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
AcelRx Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | €23.93 M | -76.18% |
| 2021-12-31 | €0.10 B | 1.26% |
| 2020-12-31 | €99.22 M | -16.28% |
| 2019-12-31 | €0.11 B | 16.61% |
| 2018-12-31 | €0.10 B | 8.83% |
| 2017-12-31 | €93.39 M | -6.73% |
| 2016-12-31 | €0.10 B | 15.65% |
| 2015-12-31 | €86.58 M | 164.65% |
| 2014-12-31 | €32.71 M | 22.54% |
| 2013-12-31 | €26.69 M | 15.14% |
| 2012-12-31 | €23.18 M | 28.87% |
| 2011-12-31 | €17.99 M | -67.09% |
| 2010-12-31 | €54.67 M | 16.07% |
| 2009-12-31 | €47.1 M | 17.56% |
| 2008-12-31 | €40.06 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Cara Therapeutics
CARA | €41.77 M | 669.79% | 🇺🇸 USA |